Skip to main content

Free Content Progress in the development of new vaccines against tuberculosis [Leading Article]

Download Article:
 Download
(PDF 3,292.1 kb)
 

Abstract:

The last few years have seen a re-emergence of interest in developing new vaccines against tuberculosis. The present article briefly reviews progress in this field, which has seen the development of several highly innovative new approaches, including the use of plasmid DNA vector-based vaccines, recombinant and mutant BCG vaccines, and sub-unit vaccines.

Keywords: BCG; DNA vaccines; animal models; sub-unit vaccines; vaccines

Document Type: Miscellaneous

Affiliations: Mycobacteria Research Laboratories, Department of Microbiology, Colorado State University, Fort Collins, Colorado, USA

Publication date: April 1, 1997

More about this publication?
  • The International Journal of Tuberculosis and Lung Disease publishes articles on all aspects of lung health, including public health-related issues such as training programmes, cost-benefit analysis, legislation, epidemiology, intervention studies and health systems research. The IJTLD is dedicated to the continuing education of physicians and health personnel and the dissemination of information on tuberculosis and lung health world-wide.

    Certain IJTLD articles are selected for translation into French, Spanish, Chinese or Russian. They are available on the Union website

  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • International Journal of Tuberculosis and Lung Disease
  • Public Health Action
  • Ingenta Connect is not responsible for the content or availability of external websites

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Partial Open Access Content
Partial Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more